Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

NCT00318799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy, Unplanned

Interventions

DRUG: EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
DRUG: SH D01155E

Sponsor

Bayer